FDA requires Chantix to have mental health warning (AP)

AP - The Food and Drug Administration will require Pfizer Inc.’s smoking cessation drug Chantix to carry the agency’s strongest safety warning over a series of mental health side effects, including depression and suicidal thoughts.

This entry was posted on Wednesday, July 1st, 2009 at 4:21 pm and is filed under Health. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.